| Pharmaceutical active ingredients: |
| Carisoprodol |
| Available forms, composition and doses of Mioriodol: |
| N / A |
| Mioriodol medical category: |
| Human:Skeletal muscle relaxants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M03BA02 - Carisoprodol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mio-Rel | Orphenadrine | Unidentified Pharmaceutical Company |
| Miorelax | Guaifenesin | Unidentified Pharmaceutical Company |
| Mioril | Carisoprodol | Unidentified Pharmaceutical Company |
| Miorilas | Methocarbamol | Unidentified Pharmaceutical Company |
| Miorilax | Chlormezanone | Unidentified Pharmaceutical Company |
| Miorrelax | Caffeine; Metamizole; Orphenadrine Citrate | Ducto Industria Farmaceutica Laboratorio |
| Mios | Carbachol; Paraoxon; Pilocarpine Hydrochloride; Procaine Hydrochloride | Industria Terapeutica Splendore - Oftalmoterapica ALFA |
| Miosal | Triethanolamine Salicylate | Ratiopharm |
| Miosan | Cyclobenzaprine Hydrochloride | Apsen Farmaceutica |
| Mio-Sed | Chlormezanone | Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mio-Rel | Orphenadrine | Unidentified Pharmaceutical Company |
| Miorelax | Guaifenesin | Unidentified Pharmaceutical Company |
| Mioril | Carisoprodol | Unidentified Pharmaceutical Company |
| Miorilas | Methocarbamol | Unidentified Pharmaceutical Company |
| Miorilax | Chlormezanone | Unidentified Pharmaceutical Company |
| Mio-Sed | Chlormezanone | Unidentified Pharmaceutical Company |
| Miotisal | Paraoxon | Unidentified Pharmaceutical Company |
| Miotisal A | Paraoxon | Unidentified Pharmaceutical Company |
| Miotran | Chlorzoxazone | Unidentified Pharmaceutical Company |
| Mipax | Dimethylphthalate | Unidentified Pharmaceutical Company |